Abdullah, S., Desai, R., Castillo, M. M. (2026). Clinically significant immune-related adverse events with perioperative pembrolizumab in early triple-negative breast cancer: Analysis of trial and real-world evidence.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.e12652